The widespread adoption of DNA methylation technologies and broad emphasis on genome research have become crucial growth factors for this industry. It is worth noting that industrial players, such as Pfizer, Roche, QIAGEN are finding key opportunities in this field and focusing on technological innovations to make them more advanced and affordable. For instance, in April 2025, EpiCypher® (a global leader in epigenomic innovation) launched CUTANA® meCUT&RUN and Multiomic CUT&RUN (affordable met...

The global healthcare simulators market size, valued at USD 3.04 billion in 2024, is projected to reach USD 3.61 billion in 2025 and USD 14.49 billion by 2035, representing a CAGR of 14.9% during the forecast period. It is worth mentioning that the need for healthcare simulators has significantly increased due to the growing medical education systems where practitioners / students can improve their skills using these innovative technologies. Driven by the ongoing demand, several industrial playe...

Currently, more than 40 industrial and non-industrial players are engaged in the development of drugs for polycystic ovary syndrome. Notably, 70% of the industrial players are very large firms. It is worth noting that these industrial players are widely emphasizing symptomatic treatment of polycystic ovary syndrome. However, with widespread demand companies like AstraZeneca are currently evaluating clinical drugs to cure PCOS condition.

The global tele-intensive care unit market size is likely to be worth USD 4.12 billion in 2025 and will reach USD 15.2 billion by 2035. In terms of the type of component, hardware segment is currently holding the highest share of the market due to the increasing demand for communication channels and video consultation tools for delivering remote care. Some of the potential opportunities in this field are technological innovations, and demand robust connectivity solutions.

The global TIL therapy market, valued at USD 0.3 billion in 2025, is projected to reach USD 0.6 billion in 2026 and USD 4.2 billion by 2035, with a 23.4% CAGR during the forecast period 2026 to 2035. TILs are a heterogeneous population of mononuclear lymphocytes that comprise of T-cells, B-cells, Natural killer cell therapies and macrophages isolated from the tumor. Notably, over 75 TIL cell therapy are being evaluated across different stages of preclinical / clinical development, either as mono...

The TCR therapy market, valued at USD 442 million in 2025, is projected to reach USD 533 million in 2026 and USD 1,563 million by 2035, with a 12.7% CAGR during the forecast period 2026 to 2035, mainly driven by the need for targeted cancer treatment for solid tumors. Presently, more than 100 industry and non-industry players across the globe are evaluating the potential of over 190 T cell receptor based immunotherapies for the treatment of various oncological and non-oncological disorders. Furt...

It is important to highlight here that the USFDA has also approved numerous cancer biosimilar products for cancer treatment, such as bevacizumab, rituximab and trastuzumab. Notably, biosimilars of bevacizumab (Avastin®) are presently available with brand name, Alymsys®, Avzivi®, Jobevne™, Mvasi®, Vegzelma® and Zirabev®. The market for oncology biosimilars in Asia-Pacific is expected to grow at a higher CAGR during the forecast period. Notably, the rising prevalence of cancer is expected...

In Asia-Pacific, the market for non-invasive fat reduction is expected to register a higher CAGR during the forecast period. This lucrative growth is likely to be fueled by the heightened social media influence and adoption of aesthetic procedures for body contouring and fat reduction. Additionally, the companies like AbbVie, and VLCC are expanding their clinical proven technologies such as CoolSculpting Elite and VLCC Lipo-1060 latest laser technology for far reduction, in Asian countries, such...

The industrial players such as Merck, Thermo Fisher Scientific and STEMCELL Technologies are increasingly emphasizing adult stem cells specifically those collected from adipose tissues / bone marrow to repair tissue damage and development of stem cell therapies for targeting wide range of diseases. In April 2025, Abu Dhabi Biobank launched an affordable private cord blood banking which offers an affordable and accessible way to preserve their newborns stem cells.

Majority of the industrial players, such as Abbott Laboratories, B. Braun and Johnson & Johnson are continually accelerating their efforts to develop single use medical kits and other supplies. In order to leverage competitive edge, several industrial players are undertaking strategic initiatives, such as latest product launch, collaborations, and partnerships.For instance, in October 2024, Verathon (subsidiary of Roper Industries) launched first Spectrum QC eco (single-use video laryngoscope) m...

The global veterinary hematology analyzers market is valued at USD 1.03 billion in 2025 and is poised to reach USD 1.74 billion by 2035, expecting to grow at a CAGR of 5.4% during the forecast period. The market is expected to be driven by the rising demand for advanced diagnostics tools, such as veterinary hematology analyzers and handheld analyzers for diagnosing infectious diseases in animals. Driven by the ongoing demand, several market players are expected to strengthen their product portfo...

The medical device labeling market, valued at USD 333 million in 2025, is projected to reach USD 365 million in 2026 and USD 509 million by 2030, with a CAGR of 8.6% during the forecast period 2026 to 2035. As of August, over 30 medical devices were approved by the US FDA alone, in 2019. However, it is worth highlighting that more than 10% of product recalls observed in this market are attributed to medical device labeling related issues. Therefore, owing to the expertise and infrastructure req...

Considering a broad scope of 4D printing in healthcare industry, several industrial players are shifting to technological innovation for manufacturing surgical robots that can perform variety of surgical tasks with higher precision, biomedical splints, implants and smart biomaterials. In July 2025, Frisco Public Library entered into partnership with Xinyl Xiao in order to launch its first public class on 4D printing program. Unlike conventional 3D printing, 4D printing helps to create structures...

The global market for cryopreservation bags and freezing bags, valued at USD 216 million in 2025, is projected to reach USD 224 million in 2026 and USD 316 million by 2035, with a 3.9% CAGR during the forecast period 2026 to 2035. The cryopreservation bags and freezing bags providers landscape features a mix of large, mid-sized and small companies that offer various cryobags. Presently, more than 70 cryogenic storage bags for biologic products have been / are being developed by over 30 industry...

According to the global sustainable agriculture market size forecast, the market is projected to grow from USD 15.43 billion in 2024 to USD 44.92 billion by 2035, representing a CAGR of 10.20%, during the forecast period 2024-2035. The expected growth during the forecast period can be attributed to several factors, including the necessity for adapting to climate change, increasing global concerns about food security, the implementation of circular economy practices, a focus on sustainable supply...

The CRISPR based genome editing service market, valued at USD 2.1 billion in 2025, is projected to reach USD 2.7 billion in 2026 and USD 5.9 billion by 2030, with a 22.1% CAGR during the forecast period 2026 to 2030. The 1970s witnessed the introduction of one of the most revolutionary advances in biotechnology, when Hamilton Smith purified the 1st site-specific restriction enzyme, called Hind II. Soon after, in the 1980s, the US FDA approved the world

The nanocellulose market size is projected to grow from USD 699 million in 2025 to USD 4,982 million by 2035, representing a CAGR of 19.54%, during the forecast period till 2035. The global nanocellulose market is expected to grow significantly over the forecast period due to the rapid industrialization in emerging economies like China and India. Additionally, some of the nanocellulose product innovations and advancements in manufacturing include microwave irradiation, enzymatic treatment, and c...

The global drug bioavailability enhancement market, valued at USD 3.6 billion in 2025, is projected to reach USD 4.0 billion in 2026 and USD 10.2 billion by 2035, with a 11.1% CAGR during the forecast period 2026 to 2035. A search study found that most candidates fail during the early phases of clinical trials. The study also underscored that almost 90% of New Chemical Entities (NCEs) in pre-clinical and clinical stages face solubility or permeability challenges. Consequently, there has been a n...

The global wireless healthcare market, valued at USD 223.83 billion in 2024, is projected to reach USD 275.91 billion in 2025 and USD 1,452.75 billion by 2035, representing a CAGR of 18.1% during the forecast period. One of the key objectives of wireless healthcare market report was to estimate the current size, opportunity, and the market growth potential, over the forecast period, till 2035. wireless healthcare market report, presently wireless personal area network accounts for the highest sh...

The diet and nutrition apps market is estimated to grow from USD 5.06 billion in 2024 to reach USD 6.13 billion in 2025 and USD 28.36 billion by 2035, representing a high CAGR of 16.6% during the forecast period. One of the key objectives of the diet and nutrition apps market report was to estimate the current size, opportunity, and the market growth potential, over the forecast period, till 2035. According to our diet and nutrition apps market report, presently, weight loss / gain tracking apps...